Engineered probiotics limit CNS autoimmunity by stabilizing HIF-1α in dendritic cells
L. M. Sanmarco, J. M. Rone, C. M. Polonio…·F. J. Quintana
The paper identifies an immunometabolic pathway in dendritic cells that limits autoimmunity and develops a synthetic probiotic to activate this pathway.